NMD4C, MDC and CSCN to Launch Clinical Fellowship Funding Competition

[updated February 3rd, 2022] The recipients of the funding competition have been announced – read the full press release!

The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) and the Canadian Society of Clinical Neurophysiologists (CSCN) are excited to announce the launch of a funding competition to award three new national clinical fellowship awards in neuromuscular medicine and electromyography! 

The awards provide salary support for early-career clinicians to participate in a neuromuscular medicine and electromyography training program, with successful applicants being eligible to receive up to $76 500 in funding over a one-year period. 

 

“Through providing fellowship opportunities for residents to pursue high-quality clinical training in the field of neuromuscular medicine and electromyography, we will create a path to practice for talented clinicians with a passion for neuromuscular disease, raising the standard of treatment and access to care for all Canadians affected by neuromuscular disease.”

-Dr. Hanns Lochmüller, Lead Investigator, NMD4C

 

The competition opens on October 8th, 2021 with the deadline for submissions being November 19, 2021. The fellowship is open to Canadian citizens or permanent residents who have completed postgraduate training in adult or paediatric neurology or physiatry in a Royal College of Physicians and Surgeons of Canada accredited program at the time of commencement of the fellowship (at least one Canadian citizen/permanent resident will be awarded funding), and International/Canadian applicants who have completed postgraduate training in adult or paediatric neurology or physiatry outside of Canada that have met the Royal College of Physicians and Surgeons of Canada requirements, if they have the support of the proposed Canadian fellowship training director. We encourage all who are eligible to apply!

 

 

A total of three clinical fellowships will be awarded on a competitive basis for the 2022/2023 academic year. These fellowships have been made possible by generous supporters of Muscular Dystrophy Canada and an unrestricted educational grant from Grifols Canada.

 

“Finding a neuromuscular specialist is an important step in a person’s healthcare journey, and we know there are few specialists across the country. Physicians can foster an environment that supports effective and informed decision-making, which is central to person-and family centred care. Together with NMD4C and CSCN, we are building a pipeline of excellence and investing in top-ranked clinicians that will provide clinical care to those affected by neuromuscular disorders and help raise standards of care.”

– Stacey Lintern, CEO, MDC


The NMD4C and MDC are committed to empowering the next generation of  early-career researchers and clinicians in building successful careers in neuromuscular disease (NMD) research and clinical practice. When provided with access to research funding and clinical fellowship opportunities, researchers and clinicians are more likely to develop core competencies, perform meaningful research and make long-term commitments to the field of NMDs. 

 

Please don’t hesitate to share this opportunity with any of your colleagues and within your neuromuscular networks. For further inquiries, please contact Dr. Erin Beattie (NMD4C) at .

Please find the fellowship guidelines here.

Fellowship_Clinical_FB

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.